Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 47(1): 35-40, 2018 01 25.
Artículo en Zh | MEDLINE | ID: mdl-30146809

RESUMEN

OBJECTIVE: : To investigate the effect of Lycium barbarum polysaccharides (LBPs) on TLR/NF-κB independent pathway and serum tumor necrosis factor (TNF-α) level in diabetic MyD88-knockout mice. METHODS: : Diabetes was induced by feeding high-fat/high-sugar diet and injection of low-dose streptozotocin in MyD88-knockout mice. The diabetic mice were randomly divided into model group, positive control group and LBPs group. The expressions of TRAM, TRIF, TRAF6, RIP1 and TNF-α mRNA and proteins in mouse peritoneal macrophages were detected by real-time RT-PCR and Western blotting after LBPs treatment for 3 month. Serum TNF-α was determined with ELISA kit. RESULTS: : Real time RT-PCR showed that compared with model group, the relative expressions of Tram, Trif, Traf6 and Tnf-α mRNA in macrophages of LBPs group were significantly decreased and expression of Rip1 was significantly increased (all P<0.05). Expression of TRAM, TRIF, TRAF6, RIP1 and TNF-α proteins as well as serum TNF-α level had no significant difference between LBPs group and model group (all P>0.05). CONCLUSIONS: : LBPs may not inhibit serum TNF-α level through TLR/NF-κB independent pathway.


Asunto(s)
Medicamentos Herbarios Chinos , Factor 88 de Diferenciación Mieloide , FN-kappa B , Transducción de Señal , Factor de Necrosis Tumoral alfa , Animales , Diabetes Mellitus Experimental , Medicamentos Herbarios Chinos/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Macrófagos Peritoneales/efectos de los fármacos , Ratones , Ratones Noqueados , Factor 88 de Diferenciación Mieloide/genética , FN-kappa B/genética , Distribución Aleatoria , Transducción de Señal/efectos de los fármacos , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/metabolismo
2.
Molecules ; 22(2)2017 Feb 22.
Artículo en Inglés | MEDLINE | ID: mdl-28241438

RESUMEN

Lycium barbarum L. polysaccharide (LBP) is prepared from Lycium barbarum L. (L. barbarum), which is a traditional Chinese medicine. LPB has been shown to have hypoglycemic effects. In order to gain some mechanistic insights on the hypoglycemic effects of LBP, we investigated the uptake of LBP and its effect on glucose absorption in the human intestinal epithelial cell line Caco2 cell. The uptake of LBP through Caco2 cell monolayer was time-dependent and was inhibited by phloridzin, a competitive inhibitor of SGLT-1. LPB decreased the absorption of glucose in Caco2 cell, and down-regulated the expression of SGLT-1. These results suggest that LBP might be transported across the human intestinal epithelium through SGLT-1 and it inhibits glucose uptake via down-regulating SGLT-1.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Glucosa/metabolismo , Hipoglucemiantes/farmacología , Lycium/química , Células CACO-2 , Metabolismo de los Hidratos de Carbono , Regulación hacia Abajo , Transportador de Glucosa de Tipo 2/metabolismo , Humanos , Absorción Intestinal , ARN Mensajero/genética , Transportador 1 de Sodio-Glucosa/metabolismo
3.
Int J Biol Macromol ; 224: 908-918, 2023 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-36283558

RESUMEN

Several studies showed the efficacy of Lycium barbarum polysaccharide (LBP) in diabetic animals and patients with type 2 diabetes mellitus (T2DM). However, the mechanism of LBP in alleviating T2DM based on glucagon-like peptide 1 (GLP1) has not been suitably elucidated. GLP1 is an important peptide that plays a role in blood glucose homeostasis. Inhibition of sodium/glucose cotransporter 1 (SGLT1) can result in a net increase in GLP1 release. We found that LBP could reduce SGLT1 expression. Thus, the effects of LBP on the first- and second-phase secretion of GLP1 were systematically assessed in vitro using STC1 cells and in vivo using diabetic KKAy mice. LBP could induce the first-phase secretion of GLP1 by stimulating calcium ion influx in vitro and by inhibiting alpha-glucosidase activity in vivo. Regulation of Gcg gene expression by modulating the Wnt/ß-catenin and cAMP/Epac pathways, as well as inhibition of alpha-glucosidase activity, was responsible for the second-phase secretion of GLP1. LBP could stimulate GLP1 secretion; however, dipeptidyl peptidase 4 (DPP4) activated by LBP might offset the second-phase secretion of GLP1. Thus, we suggest considering the simultaneous use of LBP and a DPP4 inhibitor to stimulate slow, continuous GLP1 secretion. Further studies are warranted for in-depth mechanistic information.


Asunto(s)
Diabetes Mellitus Tipo 2 , Medicamentos Herbarios Chinos , Lycium , Ratones , Animales , Péptido 1 Similar al Glucagón/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , alfa-Glucosidasas , Hipoglucemiantes/farmacología , Lycium/metabolismo
4.
Sci Total Environ ; 851(Pt 1): 158155, 2022 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-35988610

RESUMEN

In view of the strong acidity and high heavy metal contents of the soil, the low vegetation cover, and strong soil erosion caused by mining activities, the reasonable determination of the cubic restoration mode is the key to determining the good or bad ecological restoration effects on mining wasteland. In this study, based on field experiments, a combined cubic ecological restoration scheme for soil improvement-vegetation reconstruction was constructed. Using analysis of variance, a regression model, and the Mantel test, the differences in soil properties and the biodiversity were analyzed under different restoration schemes, the entropy-weighted-TOPSIS method was used to optimize the best ecological restoration model. The results revealed that compared with the pre-restoration state, the restoration significantly increased the soil pH (p < 0.05) by 4.07-5.73, regulated the strong acidic environment of the soil, increased the organic matter content by 5.35-11.21 times, and improved the soil fertility. The available contents of Pb and Cd were reduced by 67.15-75.58 % and 64.15-88.68 %, respectively compared with the background values. Biodiversity improved significantly, and the available content of Cd was an important factor in the biodiversity recovery. The evaluation of the effect of the restoration scheme showed that the combination of mixed soil amendments of rice husks and chicken manure (10 kg/m2), bacterial fertilizer (1.8 kg/m2), biochar (1.3 kg/m2), lime (8.3 kg/m2), and soil conditioner (1.0 kg/m2) and tolerant plants (Pinus elliottii, Lagerstroemia indica, and Plantago asiatica) are the optimal cubic ecological restoration scheme for the study area, with a plant survival rate of > 90 %, eight families and 10 species of plants, and a coverage rate of 100 %. These research results provide a scientific basis and technical support for reasonable artificial intervention in ecological restoration of mining waste sites in Nanling, northern Guangdong.


Asunto(s)
Metales Pesados , Contaminantes del Suelo , Cadmio/análisis , China , Fertilizantes/análisis , Plomo/análisis , Estiércol/análisis , Metales Pesados/análisis , Plantas , Suelo/química , Contaminantes del Suelo/análisis
5.
RSC Adv ; 10(56): 33955-33961, 2020 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-35519050

RESUMEN

A defect pyrochlore-type Sn1.06Nb2O5.59F0.97 (SnNbOF) nano-octahedron is used as a redox-active support for fabricating Au@SnO2 core-shell and SnO2 quantum dots at room temperature without the use of organic species or foreign reducing reagents. Gold (Au) and SnO2 components were obtained through an in situ redox reaction between the HAuCl4 and reductive Sn2+ ions incorporated in SnNbOF. The composition and morphology of the resulting nanocomposites (denoted as Au-SnNbOF) could be controlled by adjusting the Au/SnNbOF ratio. The Au-SnNbOF nanocomposites exhibited efficient photoactivities for methyl orange (MO) degradation under the visible light irradiation (λ > 420 nm), during which the MO was almost completely degraded within 8 min. Among all the samples, the 5wt% Au-SnNbOF nanocomposite had the highest rate constant (0.43 min-1), which was 40 times higher than that of the blank SnNbOF.

6.
Food Funct ; 8(5): 1741-1748, 2017 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-28401234

RESUMEN

The effects of Lycium barbarum L. (L. barbarum) on the cardiometabolic risk factors from randomized controlled trials (RCTs) have shown inconsistent results. The present meta-analysis aimed to investigate the effects of L. barbarum supplementation on the cardiometabolic risk factors. A systematic literature search was performed in Chinese National Knowledge Infrastructure (CNKI), PubMed, Scopus, and Wanfang databases updated to March 2017. The mean changes in cardiometabolic risk factors were calculated as the weighted mean difference (WMD) using a random-effects model. Seven RCTs with a total of 548 subjects were included. The pooled estimate showed that L. barbarum intervention significantly reduced the fasting glucose concentrations (-0.36 mmol L-1/-6.5 mg dL-1; 95% confident interval (CI): -0.62, -0.10 mmol L-1/-11.3, -1.8 mg dL-1). In addition, L. barbarum supplementation marginally reduced the concentrations of total cholesterol (TC) (-0.30 mmol L-1/-11.6 mg dL-1; 95% CI: -0.75, 0.15 mmol L-1/-29.0, 5.8 mg dL-1; P = 0.189) and triglyceride (TG) (-0.20 mmol L-1/-17.7 mg dL-1; 95% CI: -0.46, 0.05 mmol L-1/-40.7, 4.4 mg dL-1; P = 0.122), but the summary estimates did not reach statistical significance. No benefit was found in relation to bodyweight and blood pressure. The present meta-analysis provides some evidence that supplemental L. barbarum might have favourable effect on glucose control.


Asunto(s)
Enfermedades Cardiovasculares/tratamiento farmacológico , Lycium/química , Glucemia/metabolismo , Enfermedades Cardiovasculares/metabolismo , Enfermedades Cardiovasculares/fisiopatología , Colesterol/metabolismo , Suplementos Dietéticos/análisis , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto , Triglicéridos/metabolismo
7.
Nutr Metab (Lond) ; 14: 54, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28814963

RESUMEN

BACKGROUND: Postprandial lipemia and lipoprotein lipase (LPL) activity play crucial roles in the pathogenesis of accelerated atherosclerosis. This study aimed to evaluate the postprandial lipid metabolism after the ingestion of a liquid high-fat meal in type 2 diabetic patients with abdominal obesity, and determine if the PvuII polymorphisms of LPL influence their postprandial lipid responses. METHODS: Serum glucose, insulin, triglycerides (TG), total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) were measured in fasting and postprandial state at 0.5, 1, 2, 4, 6 and 8 h after a liquid high-fat meal in 51 type 2 diabetic patients with abdominal obesity, 31 type 2 diabetic patients without abdominal obesity and 39 controls. Their PvuII polymorphisms of LPL were tested in fasting. RESULTS: Type 2 diabetic patients with abdominal obesity had significantly higher postprandial areas under the curve (AUC) of glucose [least square mean difference (LSMD) = 30.763, 95% confidence interval (CI) = 23.071-38.455, F = 37.346, P < 0.05] and TC (LSMD = 3.995, 95% CI = 1.043-6.947, F = 3.681, P < 0.05) than controls. Postprandial AUCs for insulin, homeostasis model assessment-insulin resistance (HOMA-IR) and TG were higher (LSMD = 86.987, 95% CI = 37.421-136.553, F = 16.739, P < 0.05; LSMD = 37.456, 95% CI = 16.312-58.600, F = 27.012, P < 0.05; LSMD = 4.684, 95% CI = 2.662-6.705, F = 26.158, P < 0.05), whereas HDL-C AUC was lower (LSMD = -1.652, 95% CI = -2.685 - -0.620, F = 8.190, P < 0.05) in type 2 diabetic subjects with abdominal obesity than those without abdominal obesity. In type 2 diabetic patients with abdominal obesity, postprandial TG AUC was lower in P-/- than in P+/- (LSMD = -4.393, 95% CI = -9.278 - -0.491, F = 4.476, P < 0.05) and P+/+ (LSMD = -7.180, 95% CI = -12.319 - -2.014, F = 4.476, P < 0.05) phenotypes. Postprandial AUCs for glucose, insulin, HOMA-IR, TC and HDL-C were not different according to PvuII phenotypes. CONCLUSIONS: Abdominal obesity exacerbates the postprandial lipid responses in type 2 diabetic patients, which partly explains the excess atherogenic risk in these patients. In addition, the presence of P+ allele could contribute to a greater postprandial TG increase in type 2 diabetic patients with abdominal obesity. TRIAL REGISTRATION: ChiCTR-IOR-16008435. Registered 8 May 2016.

8.
Nutr Res ; 43: 82-88, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28673468

RESUMEN

Abdominal obesity is associated with an increased risk of insulin resistance, which may be a potential contributor to dyslipidemia. However, the relationship between postprandial insulin resistance and lipid metabolism in abdominally obese subjects remains unknown. We hypothesized that postprandial dyslipidemia would be exaggerated in abdominally obese subjects with high postprandial insulin resistance. To test this hypothesis, serum glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein cholesterol, and apolipoprotein B were measured at baseline and postprandial state at 0.5, 1, 2, 4, 6, and 8 hours after a liquid high-fat meal in non-abdominally obese controls (n=44) and abdominally obese subjects with low (AO-LPIR, n=40), middle (n=40), and high postprandial insulin resistance (AO-HPIR, n=40) based on the tertiles ratio of the insulin to glucose areas under the curve (AUC). Their serum adipokines were tested at baseline only. Fasting serum leptin was higher (P<.05) in AO-HPIR than that in AO-LPIR and controls. Postprandial triglycerides AUC was higher (P<.05), whereas high-density lipoprotein cholesterol AUC was lower (P<.05), in AO-HPIR than those in AO-LPIR and controls. Postprandial AUCs for total cholesterol and apolipoprotein B were similar in abdominally obese subjects with different degrees of postprandial insulin resistance and controls. The present study indicated that the higher degree of postprandial insulin resistance, the more adverse lipid profiles in abdominally obese subjects, which provides insight into opportunity for screening in health.


Asunto(s)
HDL-Colesterol/sangre , Dieta Alta en Grasa , Resistencia a la Insulina , Obesidad Abdominal/sangre , Periodo Posprandial , Triglicéridos/sangre , Adulto , Apolipoproteínas B/sangre , Glucemia/metabolismo , LDL-Colesterol/sangre , Dislipidemias/sangre , Femenino , Humanos , Insulina/sangre , Leptina/sangre , Metabolismo de los Lípidos , Masculino , Comidas , Persona de Mediana Edad , Tamaño de la Muestra
9.
Asia Pac J Clin Nutr ; 25(1): 213-9, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26965781

RESUMEN

BACKGROUND AND OBJECTIVES: MC4R (melanocortin-4 receptor) gene polymorphisms have been associated with serum triglycerides (TG) in Caucasians and Japanese, but no reports are available Chinese. The purpose of this study was to find whether there was an association of rs17782313 polymorphisms at the MC4R gene with serum TG in elderly Chinese. METHODS AND STUDY DESIGN: 2,012 over 40 years participated in a cross-sectional study in which their body mass index (BMI), TG, high density lipoprotein-cholesterol (HDL-C), and MC4R rs17782313 polymorphisms were determined. RESULTS: For women, carriers of the T/T genotype had significantly lower serum TG than those with C/C genotype (p=0.006). Carriers of the C/C genotype of this polymorphisms exhibited significantly lower fasting HDL-C levels compared with T/T and T/C genotypes (p=0.025), and increased glycosylated hemoglobin (HbA1c) (p=0.043), but no change in blood pressure. Higher serum TG in carriers of the C/C genotype of MC4R gene remained stable after adjustment for age, smoking, drinking, BMI, waist circumference (WC) and three or more components of the metabolic syndrome (MS) by multivariable linear regression (p=0.01) in women. The carriers of the C/C genotype of MC4R gene showed significantly greater odds ratio for TG than T/C and T/T genotypes, even when adjusted for age, smoking, drinking, BMI and WC in women. CONCLUSIONS: The rs17782313 C/C genotype is associated with higher TG levels in older Chinese women.


Asunto(s)
Polimorfismo Genético/genética , Receptor de Melanocortina Tipo 4/genética , Triglicéridos/sangre , Anciano , Envejecimiento , Índice de Masa Corporal , China , HDL-Colesterol/sangre , Estudios Transversales , Femenino , Genotipo , Hemoglobina Glucada/análisis , Humanos , Masculino , Síndrome Metabólico/genética , Persona de Mediana Edad , Factores Sexuales , Circunferencia de la Cintura
10.
Chin J Nat Med ; 13(1): 22-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25660285

RESUMEN

Non-steroidal anti-inflammatory drugs (NSAIDs) induce tissue damage and oxidative stress in animal models of stomach damage. In the present study, the protective effects of wheat peptides were evaluated in a NSAID-induced stomach damage model in rats. Different doses of wheat peptides or distilled water were administered daily by gavage for 30 days before the rat stomach damage model was established by administration of NSAIDs (aspirin and indomethacin) into the digestive tract twice. The treatment of wheat peptides decreased the NSAID-induced gastric epithelial cell degeneration and oxidative stress and NO levels in the rats. Wheat peptides significantly increased the superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities and decreased iNOS activity in stomach. The mRNA expression level of µ-opioid receptor was significantly decreased in wheat peptides-treated rats than that in in the control rats. The results suggest that NSAID drugs induced stomach damage in rats, wchih can be prevented by wheat peptides. The mechanisms for the protective effects were most likely through reducing NSAID-induced oxidative stress.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Óxido Nítrico/biosíntesis , Estrés Oxidativo/efectos de los fármacos , Proteínas de Plantas/farmacología , Receptores Opioides mu/efectos de los fármacos , Estómago/efectos de los fármacos , Triticum/química , Animales , Antioxidantes/farmacología , Aspirina/efectos adversos , Mucosa Gástrica/efectos de los fármacos , Expresión Génica , Glutatión Peroxidasa/efectos de los fármacos , Indometacina/efectos adversos , Masculino , Óxido Nítrico Sintasa/síntesis química , Oxidación-Reducción , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/efectos de los fármacos
11.
Med Chem ; 11(4): 383-90, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25381995

RESUMEN

Lycium barbarum polysaccharide (LBP) has traditionally been used in Chinese medicine as a chief ingredient of Lycium barbarum (wolf berry/goji berry) for the treatment of various diseases with the symptoms of frequent drinking and urination. This study was conducted as a randomized, controlled clinical trial. A total of 67 patients with type 2 diabetes (30 in control group and 37 in LBP group) were enrolled in this prospective, randomized, double-blind study (administration at 300 mg/day body weight). In order to observe the hypoglycemic and lipid-lowering activity of LBP in patients with type 2 diabetes after dinner, various tests were conducted between control and LBP intervention groups in 3 months. Although, the study had small sample size and short follow-up, significant findings were observed. The results of our study indicated a remarkable protective effect of LBP in patients with type 2 diabetes. Serum glucose was found to be significantly decreased and insulinogenic index increased during OMTT after 3 months administration of LBP. LBP also increased HDL levels in patients with type 2 diabetes. It showed more obvious hypoglycemic efficacy for those people who did not take any hypoglycemic medicine compared to patients taking hypoglycemic medicines. This study showed LBP to be a good potential treatment aided-agent for type 2 diabetes.


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Medicamentos Herbarios Chinos/química , Hipoglucemiantes/uso terapéutico , Lycium/química , Anciano , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/fisiopatología , Método Doble Ciego , Esquema de Medicación , Medicamentos Herbarios Chinos/aislamiento & purificación , Medicamentos Herbarios Chinos/uso terapéutico , Femenino , Humanos , Hipoglucemiantes/aislamiento & purificación , Insulina/agonistas , Insulina/sangre , Lipoproteínas HDL/agonistas , Lipoproteínas HDL/sangre , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA